[HTML][HTML] Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C Erol, MAN Sendur, I Bilgetekin… - Journal of cancer …, 2022 - journals.lww.com
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C Erol, ANS Mehmet, I Bilgetekin… - Journal of cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
[PDF][PDF] Efficacy and safety of folfiri plus aflibercept in second‑line treatment of metastatic colorectal cancer: Real‑life data from Turkish oncology group
C Erol, M Ali, N Sendur - researchgate.net
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C EROL, M ŞENDUR, I Bilgetekin… - JOURNAL OF …, 2022 - avesis.ankara.edu.tr
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C Erol, M Nahit Sendur, I Bilgetekin… - Journal of cancer …, 2022 - avesis.istanbul.edu.tr
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer Real-life data from Turkish oncology group
C Erol, MAN Şendur, İ Bilgetekin, D Bayır Garbioğlu… - 2022 - dspace.biruni.edu.tr
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
[引用][C] Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C Erol, N Sendur, I Bilgetekin, DB Garbioglu… - 2022 - acikerisim.sakarya.edu.tr
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal
cancer: Real-life data from Turkish oncology group Açık Akademik Arşiv Sistemi Efficacy …
cancer: Real-life data from Turkish oncology group Açık Akademik Arşiv Sistemi Efficacy …
[PDF][PDF] Efficacy and safety of folfiri plus aflibercept in second‑line treatment of metastatic colorectal cancer: Real‑life data from Turkish oncology group
C Erol, M Ali, N Sendur - Journal of Cancer Research and Therapeutics, 2022 - core.ac.uk
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer Real-life data from Turkish oncology group
C Erol, MAN Şendur, İ Bilgetekin, D Bayır Garbioğlu… - 2022 - openaccess.biruni.edu.tr
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
C Erol, M Nahit Sendur, I Bilgetekin… - Journal of Cancer …, 2022 - search.ebscohost.com
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …
significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) …